Egfr Mutation Positive Nsclc clinical trials

Explore recruiting egfr mutation positive nsclc clinical trials.

Recruiting egfr mutation positive nsclc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Egfr Mutation Positive Nsclc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, non-comparative, phase II study investigating the best epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) sequence in advanced or metastatic non-small-cell lung cancer (NSCLC) harboring EGFR mutations

Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Egfr Mutation Positive Nsclc trials by city

Egfr Mutation Positive Nsclc in Toronto Egfr Mutation Positive Nsclc in Vancouver Egfr Mutation Positive Nsclc in Montreal Egfr Mutation Positive Nsclc in Calgary Egfr Mutation Positive Nsclc in Edmonton Egfr Mutation Positive Nsclc in Ottawa Egfr Mutation Positive Nsclc in Winnipeg Egfr Mutation Positive Nsclc in Quebec City Egfr Mutation Positive Nsclc in Hamilton Egfr Mutation Positive Nsclc in Kitchener Egfr Mutation Positive Nsclc in London Egfr Mutation Positive Nsclc in Halifax Egfr Mutation Positive Nsclc in New York Egfr Mutation Positive Nsclc in Los Angeles Egfr Mutation Positive Nsclc in Chicago Egfr Mutation Positive Nsclc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease